BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16775188)

  • 21. The Quebec Association of Gastroenterology position paper on colorectal cancer screening - 2003.
    Barkun AN; Jobin G; Cousineau G; Dubé S; Lahaie R; Paré P; Stein B; Wassef R;
    Can J Gastroenterol; 2004 Aug; 18(8):509-19. PubMed ID: 15372115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of colorectal cancer screening in veterans based on the location of primary care clinic.
    Malhotra A; Vaughan-Sarrazin M; Charlton ME; Rosenthal GE
    J Prim Care Community Health; 2014 Jan; 5(1):24-9. PubMed ID: 24327586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitations of combined flexible sigmoidoscopy and double contrast barium enema in patients with rectal bleeding.
    Hixson LJ; Sampliner RE; Chernin M; Amberg J; Kogan F
    Eur J Radiol; 1989 Nov; 9(4):254-7. PubMed ID: 2591391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
    Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
    J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.
    Hawley ST; Volk RJ; Krishnamurthy P; Jibaja-Weiss M; Vernon SW; Kneuper S
    Med Care; 2008 Sep; 46(9 Suppl 1):S10-6. PubMed ID: 18725820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for colorectal cancer. Guidelines for choosing the appropriate test for each patient.
    Wineman AP
    Postgrad Med; 2003 Feb; 113(2):49-55; quiz 8. PubMed ID: 12611114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population screening for colorectal cancer: advantages and drawbacks.
    Kronborg O; Regula J
    Dig Dis; 2007; 25(3):270-3. PubMed ID: 17827954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S.
    Coughlin SS; Thompson TD; Seeff L; Richards T; Stallings F
    Cancer; 2002 Nov; 95(10):2211-22. PubMed ID: 12412176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative rates of missed diagnosis for colonoscopy, barium enema, and flexible sigmoidoscopy in 379 patients with colorectal cancer.
    Frenette CT; Strum WB
    J Gastrointest Cancer; 2007; 38(2-4):148-53. PubMed ID: 19089670
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.